GetTopicDetailResponse(id=a57436221a0, topicName=單片復(fù)方制劑, introduction=單片復(fù)方制劑, content=null, image=null, comments=2, allHits=1735, url=https://h5.medsci.cn/topic?id=36221, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=100641, tagList=[TagDto(tagId=100641, tagName=單片復(fù)方制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2231887, encodeId=22e7223188e69, content=<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血壓#</a> <a href='/topic/show?id=a57436221a0' target=_blank style='color:#2F92EE;'>#單片復(fù)方制劑#</a>, objectTitle=1片頂3片！《柳葉刀》：單片復(fù)方制劑額外降壓6.3 mmHg，高達96%患者可堅持用藥, objectType=article, longId=847760, objectId=a27c84e7605d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202232/1646189977052_5552845.jpg, objectUrl=/article/show_article.do?id=a27c84e7605d, replyNumber=0, likeNumber=57, createdTime=2024-10-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a27c84e7605d, moduleTitle=1片頂3片！《柳葉刀》：單片復(fù)方制劑額外降壓6.3 mmHg，高達96%患者可堅持用藥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a27c84e7605d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2120739, encodeId=29ed2120e39dd, content=<a href='/topic/show?id=017c1056e510' target=_blank style='color:#2F92EE;'>#高鈉低鉀膳食#</a>、<a href='/topic/show?id=13c5394250a' target=_blank style='color:#2F92EE;'>#吸煙#</a>、<a href='/topic/show?id=e69d1056e60b' target=_blank style='color:#2F92EE;'>#社會心理因素#</a>、<a href='/topic/show?id=05a992935f7' target=_blank style='color:#2F92EE;'>#超重#</a>和<a href='/topic/show?id=3ad9818917c' target=_blank style='color:#2F92EE;'>#肥胖#</a>、過量<a href='/topic/show?id=c37e1012082d' target=_blank style='color:#2F92EE;'>#飲酒#</a>、高齡是我國人群<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血壓#</a>發(fā)病重要的危險因素。
以前的指南推薦的常用降壓藥物包括 CCB、ACEI、ARB、噻嗪類利尿劑和 β 受體阻滯劑五類，以及由上述藥物組成的<a href='/topic/show?id=a57436221a0' target=_blank style='color:#2F92EE;'>#單片復(fù)方制劑#</a>（SPC）。補充血管緊張素受體腦啡肽酶抑制劑（<a href='/topic/show?id=3f2d2e7087' target=_blank style='color:#2F92EE;'>#ARNI#</a>）為新的一類常用降壓藥物。以上六類<a href='/topic/show?id=1e259815580' target=_blank style='color:#2F92EE;'>#降壓藥物#</a>和 SPC 均可作為初始和維持治療的常用藥物。
130~139/85~89 mmHg 的正常高值人群，心血管風(fēng)險為高危和很高危者應(yīng)立即啟動降壓藥物治療，高血壓診斷標(biāo)準(zhǔn)沒有變，但是部分人群可以干預(yù)提前。, objectTitle=2023最新中國高血壓防治指南，9 大更新要點搶先看！, objectType=article, longId=762930, objectId=69f7e62930ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=69f7e62930ff, replyNumber=0, likeNumber=214, createdTime=2023-03-21, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=69f7e62930ff, moduleTitle=2023最新中國高血壓防治指南，9 大更新要點搶先看！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=69f7e62930ff)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1241430, encodeId=623e12414309e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯醫(yī)學(xué)#</a>點評，值得深思！<a href='/topic/show?id=a57436221a0' target=_blank style='color:#2F92EE;'>#單片復(fù)方制劑#</a>確實是一個潮流，在<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>的<a href='/topic/show?id=de4119403c2' target=_blank style='color:#2F92EE;'>#一級預(yù)防#</a>和<a href='/topic/show?id=720d2401409' target=_blank style='color:#2F92EE;'>#二級預(yù)防#</a>逐步成為金標(biāo)準(zhǔn)。讓心血管的藥物研發(fā)可以緩一口氣，確實心血管的藥物研發(fā)幾乎達到某種瓶頸，很難再開發(fā)出更為有效的藥物，除非在機制方面有更大的突破。
<a href='/topic/show?id=b086512e33c' target=_blank style='color:#2F92EE;'>#心肌梗死#</a>后患者<a href='/topic/show?id=38c451e4317' target=_blank style='color:#2F92EE;'>#心血管事件#</a>，二級預(yù)防，又添強證據(jù)了！不過，細細看來，這好象又是<a href='/topic/show?id=e0df9e832a7' target=_blank style='color:#2F92EE;'>#阿斯利康#</a>的產(chǎn)品吧，確實厲害。, objectTitle=NEJM：單片復(fù)方制劑能降低心肌梗死后患者心血管事件復(fù)發(fā)（SECURE試驗）, objectType=article, longId=737183, objectId=2239e3718311, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220823/f4feed1c246d41039f348ee38de804ba.jpg, objectUrl=/article/show_article.do?id=2239e3718311, replyNumber=0, likeNumber=213, createdTime=2022-08-28, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2239e3718311, moduleTitle=NEJM：單片復(fù)方制劑能降低心肌梗死后患者心血管事件復(fù)發(fā)（SECURE試驗）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2239e3718311)], followStatus=false, userIsMember=false, type=1, lengthMark=1)]
梅斯話題小助手
2020-05-29
